These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 35258795)
1. COVID-19 Vaccination in Hemodialysis Patients Correspondence. Mungmunpuntipantip R; Wiwanitkit V High Blood Press Cardiovasc Prev; 2022 May; 29(3):311. PubMed ID: 35258795 [No Abstract] [Full Text] [Related]
2. Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines. Stumpf J; Klimova A; Mauer R; Steglich A; Gembardt F; Martin H; Glombig G; Frank K; Tonn T; Hugo C Nephrol Dial Transplant; 2022 Mar; 37(4):796-798. PubMed ID: 34791446 [No Abstract] [Full Text] [Related]
4. Clinical Utility of COVID-19 Vaccination in Patients Undergoing Hemodialysis. Oliver MJ; Blake PG Clin J Am Soc Nephrol; 2022 Jun; 17(6):779-781. PubMed ID: 35649720 [No Abstract] [Full Text] [Related]
5. Two Cases of Autoimmune Thyroid Disorders after COVID Vaccination in Dialysis Patients. Lioulios G; Tsouchnikas I; Dimitriadis C; Giamalis P; Pella E; Christodoulou M; Stangou M; Papagianni A Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232790 [TBL] [Abstract][Full Text] [Related]
6. Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection. Baimukhamedov C Int J Rheum Dis; 2021 Sep; 24(9):1218-1220. PubMed ID: 34363344 [No Abstract] [Full Text] [Related]
13. The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients. Zitt E; Davidovic T; Schimpf J; Abbassi-Nik A; Mutschlechner B; Ulmer H; Benda MA; Sprenger-Mähr H; Winder T; Lhotta K Front Immunol; 2021; 12():704773. PubMed ID: 34220867 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age-associated B cells. Mahroum N; Shoenfeld Y Int J Rheum Dis; 2022 Jan; 25(1):5-6. PubMed ID: 34978156 [No Abstract] [Full Text] [Related]
15. COVID-19 vaccination in cancer patients: Is it the time or should we wait? Arambulo S; Cabezas-Camarero S; Rojas H; Sotelo MJ J Cancer Res Ther; 2021; 17(6):1588-1589. PubMed ID: 34916405 [No Abstract] [Full Text] [Related]
16. COVID-19 vaccination in a cancerous patient: A comment. Mungmungpuntipantip R; Wiwanitkit V J Cancer Res Ther; 2021; 17(6):1587. PubMed ID: 34916404 [No Abstract] [Full Text] [Related]
17. De novo and relapsing glomerulonephritis after COVID-19 vaccination: how much do we know? Chan ATP; Tang SCW Nephrology (Carlton); 2022 Jan; 27(1):5-6. PubMed ID: 34933411 [No Abstract] [Full Text] [Related]
18. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. Schulze-Koops H; Specker C; Skapenko A RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439 [TBL] [Abstract][Full Text] [Related]
19. Reply to "The nature and severity of SARS-CoV-2 vaccines side effects are highly dependent on study design" and "Self-reported side effects following COVID-19 vaccination in athletes: Correspondence". Komici K; Verderosa S; D'Amico F; Guerra G Hum Vaccin Immunother; 2023 Aug; 19(2):2260534. PubMed ID: 37737129 [No Abstract] [Full Text] [Related]
20. Every rose has its thorns - acute myocarditis following COVID-19 vaccination. Sokolska JM; Kurcz J; Kosmala W Kardiol Pol; 2021; 79(10):1153-1154. PubMed ID: 34331307 [No Abstract] [Full Text] [Related] [Next] [New Search]